Today the company raised its full-year profit outlook after strong demand for blockbuster asthma drug Dupixent and better-than-expected sales of new launches helped its second-quarter results beat estimates.
This expanded indication enables children with this devastating diagnosis to be treated as early as possible, when there is the greatest potential to impact the natural course of disease.
Randle will manage AbelsonTaylor Group’s integrated production operations, which includes enhancing the company’s production capabilities and processes, accelerating the profitability of its post-production group, and delivering top-quality work that consistently meets the company’s high standards for creativity and business performance.
Executives from the three largest pharmacy benefit manager companies testified Tuesday before Congress that rising drug prices in the U.S. are due to pharma companies taking advantage of market exclusivities and excessive charges.
The latest job cuts across the industry for July and more.
AstraZeneca is proposing to use Imfinzi for resectable non-small cell lung cancer in the perioperative setting—both before and after surgical resection of the tumor. However, ahead of Thursday’s advisory committee meeting, FDA staffers have expressed concerns.